What? When? Why? (How?)

Size: px
Start display at page:

Download "What? When? Why? (How?)"

Transcription

1 Surgery of the Central Neck in Thyroid Cancer Dana M Hartl MD PhD Haïtham Mirghani MD Nothing to disclose Disclosure 2 Central Neck Dissection What? When? Why? (How?) What is it? Terminology for neck dissection Neck level VI: Comprehensive, compartmentoriented removal of the prelaryngeal and pretracheal nodes and at least one paratracheal lymph node basin (on at least one side) Carty et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009;19: Ferlito et al. Proposal for a rational classification of neck dissections. Head Neck 2011:33;

2 VIA VIB What is it? Level VI Removal of all fat, lymphatic, and connective tissue in the lymph node basin Limits Hyoid bone superiorly Level of the sternal notch inferiorly Common carotid artery Esophagus/prevertebral fascia Dissection and preservation Parathyroid glands (reimplantation) Recurrent nerves Thymic remnants 5 Left inferior parathyroid gland Left thymic remnant Larynx Left RLN Esophag us 6 What is it? Right RLN Inferior thyroid artery Level VI Don t forget behind the nerve on the right 7 8 2

3 What is it? Level VII Between sternal notch and innominate artery Variations with patient morphology (may not exist) Often accessible via a cervical approach What is it? Do I need to systematically resect the thymic remnants? NO: Low rate of thymic invasion (4%) Higher rate of transient hypocalcemia if thymus resected Don t resect unless necessary Extensive metastases, reoperative surgery, or level VII 9 El Khatib et al World J Surg 2010;34: What is it? What is it not? Terminology for neck dissection: «Berry picking» or removal of only a few nodes Therapeutic neck dissection Performed to remove known metastatic nodes (cn1) Clear out all gross disease Prophylactic or elective neck dissection Performed in the absence of suspected metastatic nodes (cn0) «The finger technique» or palpation in the neck searching for suspicious nodes Not recommended Carty et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009;19: Carty et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009;19:

4 When to do it? Recommendation 27 (a) Therapeutic central compartment neck dissection in patients with clinically (+imaging) involved central or lateral neck lymph nodes should accompany total thyroidectomy to provide clearance of disease from the central neck. Grade B When to do it? Metastatic nodes in the lateral neck are rarely alone Skip metastases to the lateral neck (without level VI involvement) 15-20% of patients N+ Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19: Where to do it? Level VI-VII If you can safely, remove as far down as you can to the innominate artery Bilateral? 25-50% contralateral metastases Higher if large tumor or multifocal tumor Sadowski BM et al, Surgery 2009;146: Koo BS et al, Ann Surg 2009;249: Evaluation of the extent of disease Ultrasound Contrast-enhanced CT Need to wait 4 weeks before radioiodine treament Visualization of «hidden lymph nodes» Visualization of mediastinal nodes Indicated for large or multiple neck nodes Optimize surgial excision for extensive neck disease Reoperative surgery 18 FDG-PET-CT Agressive pathological subtypes Reoperative surgery, iodine-refractory cases Padovani RP et al, Thyroid 2012;22:

5 Hidden lymph nodes: - Along superior thyroid pedicle, lateral to larynx - Behind right recurrent nerve/innominate artery - Behind common carotid artery - Behind innominate vein/sternal notch - In front of jugular/subclavian veinbehind sternoclavicular joint (Level VII) Meticulous dissection of the thyroid Visualize and preserve all parathyroids Inferior parathyroid gland With its vascular pedicle Often close to the summit of the thymic remnant Mark with a clip or small non-resorbable suture Useful if recurrence Or remove and reimplant Sinks in water Send a tiny piece to pathology for proof of identity Avoid reimplanting lymph nodes

6 21 22 Reoperative surgery Precise tumor mapping Ultrasound, CT, PET-CT Back-door approach Neuromonitoring Quicker identification of nerve Map the nerve during dissection Inferior parathyroids Difficult, try to locate the thymic remnants, dissect them then search for the parathyroid at the tip of the thymus Nodes more rarely superior to the inferior thyroid artery (superior parathyroid) Sometimes you just can t find them 23 «Back door route» Moley et al, Surgery 1999;125:

7 larynx Level VI nodes Sternothyroid muscle. Common carotid artery Why do it? 131 I not effective for gross disease Up to 30% of tumors do not show 131 I uptake Nodes with 131 I uptake coexist with those with no uptake 25 Podnos YD et al, Am Surg 2005;71: Durante C et al, JECM 2006;91: Travagli JP et al, JCEM 1998;83; Why do it? Macroscopic lymph node metastases (>1 cm) Higher rate of persistent neck disease More neck recurrences Higher mortality Justifies more agressive surgery General consensus endocrinologists, surgeons, nuclear médecine, oncologists Bardet S et al, Eur J Endocrinol 2008;158:551 Zaydfudim V et al, Surgery 2008;144:

8 What is it? Compartment-oriented neck dissection Prelaryngeal and pretracheal and at least one paratracheal basin No suspicious nodes on ultrasound Unilateral or bilateral Histological examination of a selective lymph node dissection will ordinarily include 6 or more lymph nodes. If the lymph nodes are negative, but the number ordinarily examined is not met, classify as pn0. 29 Sobin L, Gospodarowicz M, Wittekind D. TNM classification of malignant tumors, 7th edition ct1 T2 T3 N0 6 or more lymph nodes: Unilateral CND = only 42% harbored 6 or more Bilateral CND = only 78% harbored 6 or more Higher number of nodes if thyroiditis (p<.0001) n=80 n=237 Hartl DM, et al. Ann Surg When to do it? Recommendation 27 (b) Prophylactic central compartment neck dissection (ipsi or bilateral) may be performed in patients with papillary thyroid carcinoma, especially for advanced primary tumors (T3T4) grade C (expert opinion) (c) Near-total or total thyroidectomy without prophylactic central neck dissection may be appropriate for small (T1T2), noninvasive papillary cancers and most follicular cancer grade C Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:

9 When to do it? To detect and remove occult lymph node metastases Incidence of occult lymph node metastases: 30-80% Tumor size Extrathyroidal extension (T3 T4) Tumor multifocality Male gender Young age 33 Ultrasound isn t perfect! Study Hwang & Orloff 30% Morita et al 64% Ahn et al 55% Kim et al 38% Choi et al 53% Hartl et al 58% Sensitivity in the central neck, thyroid in place 34 Why do it? Why not? The battle of low-level evidence 35 Why do it? Can be performed safely without more complications than total thyroidectomy alone Chisholm EJ et al, Laryngoscope 2009;119: (meta-analysis) Avoid reoperation in the central compartment But for experienced surgeons, reoperation does not carry a higher rate of complications than primary surgery Shen WT et al, Arch Surg 2010;145:272-5 Alvarado R et al, Surgery 2009;145:

10 Prophylactic Neck Dissection Why do it? Staging pn0 versus pn1 Lower risk of recurrence for pn0 Can safely treat pn0 with lower-doses or no 131 I More 131 I and closer follow-up for pn1 Risks associated with 131 I Radiation-induced second primary cancers Salivary glands Leukemia Digestive tumors, bone, bladder Miscarriage Ageusia, dysgeusia, xerostomia Radioprotection, environmental considerations Psychological considerations, quality of life Nascimento C, et al. Endocr Relat Cancer 2011;18:R29-40 Bonnet S, et al. J Clin Endocrinol Metab 2009;94: Hughes DT, et al. Surgery 2010;148: Hartl DM, et al. Ann Surg 2012;255: Rubino C et al. Br J Cancer 2003;89: Iyer NG et al. Cancer 2011;117: Why do it? Reduce rate of reoperation in level VI 1.5% with prophylactic neck dissection versus 6.1% without, p =.004 Popadich et al, 4 year follow-up 2% versus 12%, p<.0001 IGR, 6 year follow-up Reduce rate of re-treatment (surgery or 131 I) 6.5% with prophylactic neck dissection, versus 14.7% without, p=.01 (IGR) Improved rate of retreatment-free survival Popadich A et al, Surgery 2011;150: Hartl DM et al. IGR unpublished results 39 Why not do it? No high-level evidence showing impoved disease-specific survival Meta-analysis showing no effect on disease-specific survival Roh JL et al, Ann Surg 2007;245: Bardet S et al, Eur J Endocrinol 2008;158: Zetoune T et al, Ann Surg Oncol 2010;17:

11 Why not do it? Stage I: all patients <45 M0 Why not do it? Recommendation 27 These recommendations should be interpreted in light of available surgical expertise There may be more harm than benefit in some cases Loh KC et al, J Clin Endocrinol Metab 1997;82: Staging pn0 versus pn1: Can we do it without a complete prophylactic neck dissection? Ipsilateral paratracheal neck dissection + frozen section analysis Sensitivity 78% Sentinel node biopsy: Localization rate 63-99% False negatives 0-16% But less morbidity? Conclusions Therapeutic central neck dissection General consensus of its usefulness Try to be as complete as possible Chae BJ et al, Thyroid 2011;8:1-5 Balasubramian SP et al, Br J Surg 2011;98:

12 Conclusions Special Thanks: Prophylactic cental neck dissection may have some benefits (low level evidence): Staging pn0/n1 Dose of 131 I Follow-up and prognosis Improve the rate of retreatment-free survival over the long term 45 Martin Schlumberger Chief of Radiodiagnostics, Nuclear Medicine and Endocrine Tumors Sophie Leboulleux Thyroid Tumor Board Abir Al-Ghuzlan Pathology Isabelle Borget Biostatistics and Medicoeconomics Jean-Paul Travagli, Haïtham Mirghani Thyroid Surgery Unit 46 12

Prophylactic Central Compartment Neck Dissection(CCND) for Papillary Thyroid Cancer: Con

Prophylactic Central Compartment Neck Dissection(CCND) for Papillary Thyroid Cancer: Con Prophylactic Central Compartment Neck Dissection(CCND) for Papillary Thyroid Cancer: Con Christopher R. McHenry, M.D. Vice Chairman Department of Surgery MetroHealth Medical Center Professor of Surgery

More information

Disclosures Nodal Management in Differentiated Thyroid Carcinoma

Disclosures Nodal Management in Differentiated Thyroid Carcinoma Disclosures Nodal Management in Differentiated Thyroid Carcinoma Nothing to disclose Jonathan George, MD, MPH Assistant Professor UCSF Head and Neck Oncologic & Endocrine Surgery Objectives Overview Describe

More information

Gerard M. Doherty, MD

Gerard M. Doherty, MD Surgical Management of Differentiated Thyroid Cancer: Update on 2015 ATA Guidelines Gerard M. Doherty, MD Chair of Surgery Utley Professor of Surgery and Medicine Boston University Surgeon-in-Chief Boston

More information

Reoperative central neck surgery

Reoperative central neck surgery Reoperative central neck surgery R. Pandev, I. Tersiev, M. Belitova, A. Kouizi, D. Damyanov University Clinic of Surgery, Section Endocrine Surgery University Hospital Queen Johanna ISUL Medical University

More information

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES AJC 7/14/06 1:19 PM Page 67 Thyroid C73.9 Thyroid gland SUMMARY OF CHANGES Tumor staging (T) has been revised and the categories redefined. T4 is now divided into T4a and T4b. Nodal staging (N) has been

More information

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey. Management of Differentiated Thyroid Cancer: Head Neck Surgeon Perspective Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey Thyroid gland Small endocrine gland:

More information

Persistent & Recurrent Differentiated Thyroid Cancer

Persistent & Recurrent Differentiated Thyroid Cancer Persistent & Recurrent Differentiated Thyroid Cancer Electron Kebebew University of California, San Francisco Department of Surgery Objectives Risk factors for persistent & recurrent disease Causes of

More information

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies

More information

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Its Not Just About the Nodes AACE Advances in Medical and Surgical Management of Thyroid Cancer - 2017 Robert A. Levine, MD,

More information

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies

More information

Central and lateral neck dissection for differentiated thyroid cancer Diferansiye tiroid kanserlerinde santral ve lateral boyun diseksiyonu tekniği

Central and lateral neck dissection for differentiated thyroid cancer Diferansiye tiroid kanserlerinde santral ve lateral boyun diseksiyonu tekniği Central and lateral neck dissection for differentiated thyroid cancer Diferansiye tiroid kanserlerinde santral ve lateral boyun diseksiyonu tekniği Leigh Delbridge President, International Association

More information

Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients

Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients ORIGINAL ARTICLE Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients Jianbiao Wang, MM, 1 Haili Sun, BM,

More information

Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer

Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer Well Differentiated Thyroid Cancer Natural History and Prognosis EORTC AGES AMES MACIS QuickTime and a TIFF (LZW) decompressor

More information

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel

More information

Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study

Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study Original Article Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study Qiang Chen, Xiu-He Zou, Tao Wei, Qiu-Shi Huang,

More information

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release 2 REVISION HISTORY Date Author / Editor Comments 5/19/2014 Jaleh Mirza Created the document 8/12/2014 Samantha Spencer/Jaleh

More information

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF MICHIGAN MICHIGAN AACE 2018 ANNUAL MEETING Thyroid Cancer: When Not to Treat? FOCUS WILL BE ON LOW-RISK

More information

Thyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary

Thyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - medical and surgical management JRE Davis NR Parrott Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - prevalence Thyroid nodules common, increase with

More information

Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler, MD, Roee Landsberg, MD, Dan M. Fliss, MD

Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler, MD, Roee Landsberg, MD, Dan M. Fliss, MD ORIGINAL ARTICLE ELECTIVE PARATRACHEAL NECK DISSECTION FOR LATERAL METASTASES FROM PAPILLARY CARCINOMA OF THE THYROID: IS IT INDICATED? Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler,

More information

Thyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas.

Thyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas. Thyroid Gland Protocol applies to all malignant tumors of the thyroid gland, except lymphomas. Procedures Cytology (No Accompanying Checklist) Partial Thyroidectomy Total Thyroidectomy With/Without Lymph

More information

Surgery for Recurrent Thyroid cancer: Considerations and limitations

Surgery for Recurrent Thyroid cancer: Considerations and limitations Surgery for Recurrent Thyroid cancer: Considerations and limitations 2016 Thyroid Master Class February 13, 2016 Ara A. Chalian MD, FACS Surgical Patient Safety Officer University Of Pennsylvania Health

More information

Preoperative Evaluation

Preoperative Evaluation Preoperative Evaluation Lateral compartment lymph nodes are easier to detect and are amenable to FNA Central compartment lymph nodes are much more difficult to detect and FNA (Tg washout testing is compromised)

More information

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine THYROID CANCER IN CHILDREN Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine Thyroid nodules Rare Female predominance 4-fold as likely to be malignant Hx Radiation exposure?

More information

Dynamic Risk Stratification:

Dynamic Risk Stratification: Dynamic Risk Stratification: Using Risk Estimates to Guide Initial Management R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine

More information

How Will (Should) the Latest Guidelines Affect the Endocrinologist s Management of Thyroid Cancer? AACE 2017

How Will (Should) the Latest Guidelines Affect the Endocrinologist s Management of Thyroid Cancer? AACE 2017 How Will (Should) the Latest Guidelines Affect the Endocrinologist s Management of Thyroid Cancer? AACE 2017 Bryan R. Haugen, MD University of Colorado, School of Medicine Outline Some statistics New guidelines

More information

40 TH EUROPEAN CONGRESS 0F CYTOLOGY LIVERPOOL, UK October 2-5, 2016

40 TH EUROPEAN CONGRESS 0F CYTOLOGY LIVERPOOL, UK October 2-5, 2016 Outcomes from the diagnostic approach of thyroid lesions using US-FNA and LBC in clinical practice Emmanouel Mastorakis MD PhD Cytopathologist Director in Cytopathology Laboratory Regional General Hospital

More information

Accepted 12 August 2013 Published online 27 November 2013 in Wiley Online Library (wileyonlinelibrary.com). DOI /hed.23451

Accepted 12 August 2013 Published online 27 November 2013 in Wiley Online Library (wileyonlinelibrary.com). DOI /hed.23451 ORIGINAL ARTICLE Risk factors and clinical indication of metastasis to lymph nodes posterior to right recurrent laryngeal nerve in papillary thyroid carcinoma: A single-center study in China Zhang Pinyi,

More information

Current Issues in Thyroid Cancer Surgery in 2017

Current Issues in Thyroid Cancer Surgery in 2017 Current Issues in Thyroid Cancer Surgery in 2017 Dr. David Goldstein MD Msc FRCSC FACS Associate Professor, Department Otolaryngology Head & Neck Surgery, U of T Department of Surgical Oncology, Princess

More information

Management of Recurrent Thyroid Cancer

Management of Recurrent Thyroid Cancer Management of Recurrent Thyroid Cancer Eric Genden, MD, MHA Isidore Professor and Chairman Department of Otolaryngology- Head and Neck Surgery Senior Associate Dean for Clinical Affairs The Icahn School

More information

Title. CitationInternational Cancer Conference Journal, 4(1): Issue Date Doc URL. Rights. Type. File Information

Title. CitationInternational Cancer Conference Journal, 4(1): Issue Date Doc URL. Rights. Type. File Information Title Lymph node metastasis in the suprasternal space from Homma, Akihiro; Hatakeyama, Hiromitsu; Mizumachi, Ta Author(s) Tomohiro; Fukuda, Satoshi CitationInternational Cancer Conference Journal, 4(1):

More information

WTC 2013 Panel Discussion: Minimal disease

WTC 2013 Panel Discussion: Minimal disease WTC 2013 Panel Discussion: Minimal disease Susan J. Mandel MD MPH Panelists Ken Ain Yasuhiro Ito Stephanie Lee Erich Sturgis Mark Urken Faculty/Presenter Disclosure Relationships with commercial interests

More information

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate Head & Neck Clinical Sub Group Network Agreed Imaging Guidelines for UAT and Thyroid Cancer Measure Nos: 11-1C-105i &

More information

Adjuvant therapy for thyroid cancer

Adjuvant therapy for thyroid cancer Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women

More information

Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer

Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer A rational approach to longterm follow-up based on dynamic risk assessment. World Congress on Thyroid

More information

Thyroid Neoplasm. ORL-Head and neck Surgery 2014

Thyroid Neoplasm. ORL-Head and neck Surgery 2014 In The Name of God Thyroid Neoplasm ORL-Head and neck Surgery 2014 Malignant Neoplasm By age 90, virtually everyone has nodules Estimates of cancer prevalence at autopsy 4% to 36% Why these lesions are

More information

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status New Perspectives in Thyroid Cancer Jennifer Sipos, MD Assistant Professor of Medicine Division of Endocrinology The Ohio State University Outline Thyroid Nodules Thyroid Cancer Epidemiology Initial management

More information

Differentiated Thyroid Cancer: Initial Management

Differentiated Thyroid Cancer: Initial Management Page 1 ATA HOME GIVE ONLINE ABOUT THE ATA JOIN THE ATA MEMBER SIGN-IN INFORMATION FOR PATIENTS FIND A THYROID SPECIALIST Home Management Guidelines for Patients with Thyroid Nodules and Differentiated

More information

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB. 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

ATA Guidelines for Medullary Thyroid Cancer: approach to initial management of sporadic and inherited disease

ATA Guidelines for Medullary Thyroid Cancer: approach to initial management of sporadic and inherited disease ATA Guidelines for Medullary Thyroid Cancer: approach to initial management of sporadic and inherited disease Richard T. Kloos, M.D. The Ohio State University Divisions of Endocrinology and Nuclear Medicine

More information

The role of prophylactic central compartment lymph node dissection in differentiated thyroid carcinoma

The role of prophylactic central compartment lymph node dissection in differentiated thyroid carcinoma Original Research Article The role of prophylactic central compartment lymph node dissection in differentiated thyroid carcinoma Nived Rao 1, M. Muralidhar 2*, M. Srinivasulu 3 1Senior Resident in Surgical

More information

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study ORIGINAL ARTICLE A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study Joon-Hyop Lee, MD, Yoo Seung Chung, MD, PhD,* Young Don Lee, MD, PhD

More information

MEDIASTINAL STAGING surgical pro

MEDIASTINAL STAGING surgical pro MEDIASTINAL STAGING surgical pro Paul E. Van Schil, MD, PhD Department of Thoracic and Vascular Surgery University of Antwerp, Belgium Mediastinal staging Invasive techniques lymph node mapping cervical

More information

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose. Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for

More information

Central Lymph Node Dissection In Patients With Papillary Thyroid Cancer: A Population Level Analysis Of Cases

Central Lymph Node Dissection In Patients With Papillary Thyroid Cancer: A Population Level Analysis Of Cases Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2013 Central Lymph Node Dissection In Patients With Papillary

More information

Overview. Extraglandular Thyroid Lymphatics. Management of the Lateral Neck in Well-Differentiated Thyroid Carcinoma. David W. Eisele, M.D., F.A.C.S.

Overview. Extraglandular Thyroid Lymphatics. Management of the Lateral Neck in Well-Differentiated Thyroid Carcinoma. David W. Eisele, M.D., F.A.C.S. Management of the Lateral Neck in Well-Differentiated Thyroid Carcinoma David W. Eisele, M.D., F.A.C.S. Head and Neck Surgery and Oncology U.C.S.F. Comprehensive Cancer Center University of California,

More information

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA

More information

New York, the nation s thyroid gland. Christopher Morley ( ), "Shore Leave"

New York, the nation s thyroid gland. Christopher Morley ( ), Shore Leave New York, the nation s thyroid gland Christopher Morley (1890-1957), "Shore Leave" Thyroid Literature Medline Thyroid disease 136,053 Thyroid tumors 33,554 New Paper on Thyroid Disease Every 3 Hours New

More information

Management guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007

Management guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007 Management guideline for patients with differentiated thyroid Teeraporn Ratanaanekchai ENT, KKU 17 October 2007 Incidence (Srinagarind Hospital, 2005, both sex) Site (all) cases % 1. Liver 1178 27 2. Lung

More information

Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer

Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer DEBATE WJOES Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer Ashok R Shaha

More information

ORIGINAL ARTICLE. The Importance of Central Compartment Elective Lymph Node Excision in the Staging and Treatment of Papillary Thyroid Cancer

ORIGINAL ARTICLE. The Importance of Central Compartment Elective Lymph Node Excision in the Staging and Treatment of Papillary Thyroid Cancer ORIGINAL ARTICLE The Importance of Central Compartment Elective Lymph Node Excision in the Staging and Treatment of Papillary Thyroid Cancer Maisie Shindo, MD; James C. Wu, MD; Eunice E. Park, MPH; Frances

More information

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines 2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines Angela M. Leung, MD, MSc, ECNU November 5, 2016 Outline Workup of nontoxic thyroid nodule(s) Ultrasound FNAB Management of FNAB results

More information

Risk Adapted Follow-Up

Risk Adapted Follow-Up Risk Adapted Follow-Up Individualizing Follow- Up Strategies R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Medical College

More information

Locally advanced papillary thyroid cancer

Locally advanced papillary thyroid cancer Locally advanced papillary thyroid cancer Educational Session 12 th October 2015 Presenters: Smith JA, Carr-Boyd E Supervisors: Palme CE, Elliott M, Navin N, Gupta R Content Case report Imaging Primary

More information

Introduction. Materials and methods Y-N XU 1,2, J-D WANG 1,2

Introduction. Materials and methods Y-N XU 1,2, J-D WANG 1,2 1 di 5 11/04/2016 17:54 G Chir Vol. 31 - n. 5 - pp. 205-209 Maggio 2010 Y-N XU 1,2, J-D WANG 1,2 Introduction The World Health Organization (WHO) defined papillary thyroid microcarcinomas (PTMC) as tumors

More information

I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER

I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS Advances in Medical and Surgical Management of Thyroid Cancer January 23-24, 2015 I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER 2015 Leonard Wartofsky,

More information

An Unexpected Cause of Hypoglycemia

An Unexpected Cause of Hypoglycemia An Unexpected Cause of Hypoglycemia Stacey A. Milan, MD FACS Surgical Oncology Nothing to disclose Disclosures Objectives Identify indications for workup of hypoglycemia Define work up for hypoglycemic

More information

Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence

Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence ORIGINAL ARTICLE Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence Young Min Park, MD, PhD, 1 Soo-Geun Wang, MD, PhD,

More information

Differentiated Thyroid Carcinoma

Differentiated Thyroid Carcinoma Differentiated Thyroid Carcinoma The GOOD cancer? Jennifer Sipos, MD Associate Professor of Medicine Director, Benign Thyroid Program Division of Endocrinology, Diabetes and Metabolism The Ohio State University

More information

Surgical anatomy of thyroid and parathyroid glands

Surgical anatomy of thyroid and parathyroid glands Head & Neck Surgery Course Surgical anatomy of thyroid and parathyroid glands Dr Pierfrancesco PELLICCIA Pr Benjamin LALLEMANT Service ORL et CMF CHU de Nîmes CH de Arles Thyroid glands Dr Pierfrancesco

More information

PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW DISCLOSURES

PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW DISCLOSURES PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW Miguel Hernandez Pampaloni, M.D., Ph.D. Chief, Nuclear Medicine Assistant Professor of Radiology UCSF Department of Radiology and Biomedical Imaging DISCLOSURES

More information

유두상갑상선암종에서경부림프절전이의양상및치료

유두상갑상선암종에서경부림프절전이의양상및치료 KISEP Head and Neck Korean J Otolaryngol 2005;48:506- 유두상갑상선암종에서경부림프절전이의양상및치료 태경 전성하 이현창 김경래 이형석 박용수 2 안유헌 2 김태화 2 Pattern and Treatment of Papillary Thyroid Carcinoma with Cervical Lymph Node Metastasis

More information

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

Thyroid Ultrasound for the Endocrine Surgeon: A Valuable Clinical Tool that Enhances Diagnostic and Therapeutic Outcomes

Thyroid Ultrasound for the Endocrine Surgeon: A Valuable Clinical Tool that Enhances Diagnostic and Therapeutic Outcomes Thyroid Ultrasound for the Endocrine Surgeon: A Valuable Clinical Tool that Enhances Diagnostic and Therapeutic Outcomes Allan Siperstein MD The Cleveland Clinic Audience Quiz Taken ultrasound course Perform

More information

Original Article Correlation analysis on central lymph node metastasis in 276 patients with cn0 papillary thyroid carcinoma

Original Article Correlation analysis on central lymph node metastasis in 276 patients with cn0 papillary thyroid carcinoma Int J Clin Exp Pathol 2013;6(3):510-515 www.ijcep.com /ISSN:1936-2625/IJCEP1211043 Original Article Correlation analysis on central lymph node metastasis in 276 patients with cn0 papillary thyroid carcinoma

More information

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted

More information

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50% Pinhole images of the neck are acquired in multiple projections, 24hrs after the oral administration of approximately 200 µci of I123. Usually, 24hr uptake value if also calculated (normal 24 hr uptake

More information

Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus

Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus ORIGINAL ARTICLE Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus Chang Myeon Song, MD, 1 Dong Won Lee, MD, 1 Yong Bae Ji, MD, PhD, 1 Jin Hyeok Jeong,

More information

American Head and Neck Society - Journal Club Volume 22, July 2018

American Head and Neck Society - Journal Club Volume 22, July 2018 - Table of Contents click the page number to go to the summary and full article link. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated

More information

RESEARCH ARTICLE. Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer

RESEARCH ARTICLE. Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer RESEARCH ARTICLE Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer Zekiye Hasbek 1 *, Bulent Turgut 1, Fatih Kilicli 2,

More information

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries REVIEW ARTICLE J Korean Thyroid Assoc Vol. 4, No. 2, November 2011 Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries Yasuhiro Ito, MD and Akira Miyauchi, MD

More information

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans 131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans Anca M. Avram, M.D. Associate Professor of Radiology Department of Nuclear Medicine University of Michigan Ann Arbor,

More information

Thyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis

Thyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis Most thyroid nodules are benign Thyroid nodules Postgraduate Course in General Surgery thyroid nodules occur in 77% of the world s population palpable thyroid nodules occur in about 5% of women and 1%

More information

PARATHYROID IMAGING. James Lee, MD Chief, Endocrine Surgery Co-Director NY Thyroid-Parathyroid Center Columbia University Medical Center

PARATHYROID IMAGING. James Lee, MD Chief, Endocrine Surgery Co-Director NY Thyroid-Parathyroid Center Columbia University Medical Center PARATHYROID IMAGING James Lee, MD Chief, Endocrine Surgery Co-Director NY Thyroid-Parathyroid Center Columbia University Medical Center NO DISCLOSURES Overview The hallmarks of the ideal test Benefits

More information

Clinical predictors of right upper paraesophageal lymph node metastasis from papillary thyroid carcinoma

Clinical predictors of right upper paraesophageal lymph node metastasis from papillary thyroid carcinoma Kim and Park World Journal of Surgical Oncology 2012, 10:164 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Clinical predictors of right upper paraesophageal lymph node metastasis from papillary

More information

Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting?

Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting? Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting? Jacob Moalem, MD, FACS Associate Professor Endocrine Surgery and Endocrinology URMC Agenda 1. When is lobectomy alone

More information

Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection

Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection Deutschmann et al. Journal of Otolaryngology - Head and Neck Surgery (2016) 45:55 DOI 10.1186/s40463-016-0169-8 ORIGINAL RESEARCH ARTICLE Open Access Practice patterns among thyroid cancer surgeons: implications

More information

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary Surgery for Well-differentiated Thyroid Carcinoma- The Primary Head and Neck Endocrine Surgery Department of Otolaryngology-Head and Neck Surgery, UCSF October 24-25, 2008 Robert A. Sofferman, MD Professor

More information

PAPER. Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma

PAPER. Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma PAPER Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma Sendia Kim, MD; John P. Wei, MD; Joshua M. Braveman, MD; David M. Brams, MD Hypothesis: The prognosis of papillary thyroid

More information

Research Article A Study on Central Lymph Node Metastasis in 543 cn0 Papillary Thyroid Carcinoma Patients

Research Article A Study on Central Lymph Node Metastasis in 543 cn0 Papillary Thyroid Carcinoma Patients International Endocrinology Volume 2016, Article ID 1878194, 5 pages http://dx.doi.org/10.1155/2016/1878194 Research Article A Study on Central Lymph Node Metastasis in 543 cn0 Papillary Thyroid Carcinoma

More information

Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits?

Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits? Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits? Julie Ann Sosa, MD MA FACS Professor of Surgery and Medicine Chief, Section of Endocrine

More information

2. Patients & Methods

2. Patients & Methods Journal of Surgery 2017; 5(6): 124-129 http://www.sciencepublishinggroup.com/j/js doi: 10.11648/j.js.20170506.17 ISSN: 2330-0914 (Print); ISSN: 2330-0930 (Online) Total Thyroidectomy Without Prophylactic

More information

The use of Radioactive Iodine (RAI) for Differentiated Thyroid Cancer

The use of Radioactive Iodine (RAI) for Differentiated Thyroid Cancer The use of Radioactive Iodine (RAI) for Differentiated Thyroid Cancer Wendy Sacks, M.D. Cedars Sinai Medical Center California Chapter Annual Meeting, AACE Nov 5, 2016 Increasing Incidence of Thyroid Cancer

More information

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer Thyroid Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: 1. Lenvina is the first line therapy with powerful durable response and superior PFS in pts with RAI-refractory disease.

More information

Thyroid and Adrenal Gland

Thyroid and Adrenal Gland Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-

AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY- TX: primary tumor cannot be assessed T0: no evidence of primary tumor Tis: carcinoma in situ. T1: tumor is 2 cm or smaller AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY- T2:

More information

Lang, BHH; Lee, GCC; Ng, CPC; Wong, KP; Wan, KY; Lo, CY. Citation World Journal of Surgery, 2013, v. 37 n. 12, p

Lang, BHH; Lee, GCC; Ng, CPC; Wong, KP; Wan, KY; Lo, CY. Citation World Journal of Surgery, 2013, v. 37 n. 12, p Title Evaluating the Morbidity and Efficacy of Reoperative Surgery in the Central Compartment for Persistent/Recurrent Papillary Thyroid Carcinoma Author(s) Lang, BHH; Lee, GCC; Ng, CPC; Wong, KP; Wan,

More information

Thyroid Cancer (Carcinoma)

Thyroid Cancer (Carcinoma) Information for Patients Thyroid Cancer (Carcinoma) Prepared by the American Association of Clinical Endocrinologists (AACE), a not-for-profit national organization of highly qualified specialists in hormonal

More information

PET/CT Frequently Asked Questions

PET/CT Frequently Asked Questions PET/CT Frequently Asked Questions General Q: Is FDG PET specific for cancer? A: No, it is a marker of metabolism. In general, any disease that causes increased metabolism can result in increased FDG uptake

More information

Thyroidectomy. Siu Kwan Ng. Modified Radical Neck Dissection Type II 47

Thyroidectomy. Siu Kwan Ng. Modified Radical Neck Dissection Type II 47 06 Thyroidectomy Siu Kwan Ng Modified Radical Neck Dissection Type II 47 Thyroidectomy STEP 1. EXPOSING THE THYROID GLAND The collar incision Figure 1 (curvilinear skin crease incision) is made at 1.5-2

More information

Imaging in Thyroid Cancer

Imaging in Thyroid Cancer Imaging in Thyroid Cancer Susan J. Mandel MD MPH University of Pennsylvania School of Medicine Philadelphia, PA I-123 Ultrasound Background Radioiodine ablation of thyroid remnants after surgery is a generally

More information

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women Thyroid cancer- what s new Thyroid Cancer Changing epidemiology Molecular markers Lymph node dissection Technical advances rhtsh Genetic testing and prophylactic surgery Vandetanib What s new? Jessica

More information

THYROID CANCER IN CHILDREN

THYROID CANCER IN CHILDREN THYROID CANCER IN CHILDREN Isabel ROCA, Montserrat NEGRE Joan CASTELL HU VALL HEBRON BARCELONA EPIDEMIOLOGY ADULTS males 1,2-2,6 cases /100.000 females 2,0-3,8 cases /100.000 0,02-0,3 / 100.000 children

More information

The clinical prognosis of patients with cn0 papillary thyroid microcarcinoma by central neck dissection

The clinical prognosis of patients with cn0 papillary thyroid microcarcinoma by central neck dissection Zhang et al. World Journal of Surgical Oncology (2015) 13:138 DOI 10.1186/s12957-015-0553-2 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access The clinical prognosis of patients with cn0 papillary

More information

Coexistence of parathyroid adenoma and papillary thyroid carcinoma. Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park

Coexistence of parathyroid adenoma and papillary thyroid carcinoma. Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park J Korean Surg Soc 2011;81:316-320 http://dx.doi.org/10.4174/jkss.2011.81.5.316 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Coexistence of parathyroid

More information

PAPILLARY THYROID CARCINOMA PRESENTING AS A LATERAL NECK MASS MASS. Dr. Pamela Hanson DO PGY3

PAPILLARY THYROID CARCINOMA PRESENTING AS A LATERAL NECK MASS MASS. Dr. Pamela Hanson DO PGY3 PAPILLARY THYROID CARCINOMA PRESENTING AS A LATERAL NECK MASS MASS Dr. Pamela Hanson DO PGY3 MK CASE PRESENTATION 28 yo Female presented to the ENT Clinic in October 2016, with the complaint of chronic

More information

Thyroid nodules. Most thyroid nodules are benign

Thyroid nodules. Most thyroid nodules are benign Thyroid nodules Postgraduate Course in General Surgery Jessica E. Gosnell MD Assistant Professor March 22, 2011 Most thyroid nodules are benign thyroid nodules occur in 77% of the world s population palpable

More information

Resection margins and prognosis in locally invasive thyroid cancer

Resection margins and prognosis in locally invasive thyroid cancer ORIGINAL ARTICLE Resection margins and prognosis in locally invasive thyroid cancer Dana M. Hartl, MD, PhD, 1* Sophie Zago, MD, 1 Sophie Leboulleux, MD, 2 Ha ıtham Mirghani, MD, 1 Desiree Deandreis, MD,

More information

Hyo Sub Keum 1, Yong Bae Ji 1, Jong Min Kim 1, Jin Hyeok Jeong 1, Woong Hwan Choi 2, You Hern Ahn 2 and Kyung Tae 1*

Hyo Sub Keum 1, Yong Bae Ji 1, Jong Min Kim 1, Jin Hyeok Jeong 1, Woong Hwan Choi 2, You Hern Ahn 2 and Kyung Tae 1* Keum et al. World Journal of Surgical Oncology 2012, 10:221 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Optimal surgical extent of lateral and central neck dissection for papillary thyroid

More information

Reference No: Author(s) Approval date: October committee. September Operational Date: Review:

Reference No: Author(s) Approval date: October committee. September Operational Date: Review: Reference No: Title: Author(s) Systemic Anti-Cancer Therapy (SACT) guidelines for Thyroid cancer Dr Fionnuala Houghton Consultant Clinical Oncologist & Dr Lois Mulholland Consultant Clinical Oncologist

More information

Lymph node management in clinically node-negative patients with papillary thyroid carcinoma

Lymph node management in clinically node-negative patients with papillary thyroid carcinoma Lymph node management in clinically node-negative patients with papillary thyroid carcinoma S. Vergez, J. Sarini, J. Percodani, E. Serrano, Ph Caron To cite this version: S. Vergez, J. Sarini, J. Percodani,

More information